Oxycodone Drugs Market Report 2026

Oxycodone Drugs Market Overview

• Oxycodone Drugs market size has reached to $5.98 billion in 2025 • Expected to grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: The Rising Burden Of Orthopedic Disorders Fueling Market Growth Due To Increasing Musculoskeletal Disease Prevalence • Market Trend: Advancements In Abuse-Deterrent Pain Therapies Gain Momentum • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oxycodone Drugs Market?

Oxycodone drug is a potent opioid analgesic medication used primarily for the management of moderate to severe pain. It belongs to the class of drugs known as opioid agonists, which act on specific receptors in the brain and spinal cord to alter the perception of pain. Oxycodone drug is an effective pain management option when used appropriately and under the supervision of a healthcare provider. The main drug types of oxycodone drugs are short-acting oxycodone and long-acting oxycodone. Short-acting oxycodone refers to formulations of the drug that provide immediate pain relief but have a shorter duration of action, commonly used for managing acute pain conditions such as post-operative discomfort or injury-related pain. The dosage form of oxycodone drugs includes tablets, capsules, and injections, and the indications are neuropathic pain, musculoskeletal pain, cancer pain, postoperative pain, and others. It is distributed using various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies.

What Is The Oxycodone Drugs Market Growth Forecast?

The oxycodone drugs market size is expected to see strong growth in the next few years. It will grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to stricter opioid prescribing regulations, growth of controlled-release pain management, increasing cancer and chronic pain cases, expansion of pain management clinics, development of safer opioid formulations. Major trends in the forecast period include shift toward abuse-deterrent oxycodone formulations, rising use of extended-release pain management therapies, growing preference for hospital-based opioid administration, increasing emphasis on prescription monitoring and compliance, expansion of generic oxycodone products in regulated markets.

Global Oxycodone Drugs Market Segmentation

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone 2) By Dosage Form: Tablets, Capsules, Injections 3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution 2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

What Is The Driver Of The Oxycodone Drugs Market?

The rising burden of orthopedic disorders is expected to propel the growth of the oxycodone drug market going forward. Orthopedic disorders refer to conditions that affect the bones, joints, ligaments, tendons, and muscles, often resulting in chronic pain, reduced mobility, and long-term functional limitations. The surge in orthopedic conditions is driven by factors such as population aging, sedentary lifestyles, obesity, sports-related injuries, and occupational strain. Oxycodone drugs support effective pain management by providing relief for acute and chronic orthopedic pain, including fractures, joint damage, and post-surgical recovery, through their action on pain receptors in the central nervous system. For instance, in February 2024 according to the Arthritis Australia is a Australia-based non-profit organization In 2025, an estimated 212,136 males and 362,137 females are projected to have rheumatoid arthritis (RA), with the numbers expected to rise by 2040 to approximately 280,040 males and 479,828 females. Therefore, the rising burden of orthopedic disorders is driving the growth of the oxycodone drug industry.

Key Players In The Global Oxycodone Drugs Market

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

Global Oxycodone Drugs Market Trends and Insights

Major companies operating in the oxycodone drug market are prioritizing the development of advanced abuse-deterrent immediate-release (IR) formulations to reduce the risk of misuse via injection and intranasal administration. Abuse-deterrent IR opioids incorporate physical and chemical barriers that make tablets difficult to crush, dissolve, or manipulate for non-oral routes, thereby enhancing patient safety and minimizing diversion. For instance, in October 2024, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, received FDA approval for ROXYBOND™ (oxycodone hydrochloride) 10 mg immediate-release tablets incorporating patented SentryBond abuse-deterrent technology. This technology is engineered to resist physical manipulation and chemical extraction, making the tablets difficult to cut, crush, or dissolve for misuse through intranasal or intravenous routes. As a result, it lowers the potential for abuse while still delivering effective immediate-release pain relief for patients whose severe pain requires opioid therapy when other treatment options are insufficient.

What Are Latest Mergers And Acquisitions In The Oxycodone Drugs Market?

In February 2023, UNC Kenan-Flagler Business School, a US-based University for the Business of Health (CBOH), partnered with Acadia Healthcare to develop an adaptable opioid settlement playbook. This partnership aims to guide the most effective ways for communities to utilize opioid settlement funds, especially as communities across the U.S., including North Carolina, are receiving significant funds to support opioid recovery efforts from legal settlements with opioid manufacturers and pharmacy chains. Acadia Healthcare Company Inc. is a US-based provider of behavioral healthcare services.

Regional Insights

North America was the largest region in the oxycodone drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oxycodone Drugs Market?

The oxycodone drugs market consists of sales of codeine, morphine, hydrocodone, fentanyl, and methadone. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oxycodone Drugs Market Report 2026?

The oxycodone drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oxycodone drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.